Featured Image for BIOGNOSYS, INC.

proteomics, vaccine and drug development, clinical testing, mass spectrometry, biomarker

Large scale discovery and targeted proteomics: Biognosys’ mass spectrometry-based proteomics solutions enable research with unprecedented precision, depth, and scale. Powered by our cutting-edge technology, extensive facility, and state-of-the-art data analytics, we provide deep, large-scale insights on the molecular phenotype, enabling breakthrough discoveries and bringing life science to a new level.

Vendor Profile

UEI: G6GVGLBNL3B1

CAGE: 9ZDG9

Primary NAICS: 621511 - Medical Laboratories